Promising New Therapies for Managing Tourette Syndrome

A device that stimulates the median nerve and a D1 receptor antagonist are among the promising new treatment approaches for patients with Tourette syndrome (TS), according to an overview of new therapies presented at the XXVI World Congress of Neurology (WCN).

One recent study by University of Nottingham researchers showed a wrist-worn stimulating device significantly reduces the frequency and severity of tics — repetitive movements or vocalizations that can occur several times a day.

"Wearable nerve stimulation holds great promise because it will be good across the age spectrum; adults can wear it to work, and children can go to school with it to help them concentrate on their schoolwork, and then they take it off at night," Eileen Joyce, PhD, MB BChir, professor of neuropsychiatry at the Institute of Neurology, University College London, UK, told Medscape Medical News.

XXVI World Congress of Neurology (WCN). Session on Neuropsychiatry of Movement Disorders. Presented October 15, 2023.

Source: MEDspace